GLUE Monte Rosa Therapeutics, Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
11:40
Aug 03
seedy19tron
No upside case for GLUE post-NVO
Avoid GLUE post-NVO readouts — author sees no identifiable upside catalyst, expects a slow bleed lower, and explicitly declines to take a position.
GLUE Monte Rosa Therapeutics, Inc. Avoid — —
00:52
Jan 07
u/IJesusChrist
r/pennystocks
Long GLUE on VTYX acquisition spillover
Author includes GLUE among companies that would go up more if VTYX is acquired. GLUE is noted to have chosen a different upstream target but remains in the same catalyst group.
GLUE Monte Rosa Therapeutics, Inc. Long 1ST — —

About GLUE Investor Commentary

Across the available history and selected sources, Buzzberg tracks GLUE (Monte Rosa Therapeutics, Inc.) across 3 sources: 1 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 25% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 4 total trade ideas tracked. Latest voices: seedy19tron, u/IJesusChrist.